Antibiotic resistance pattern of community acquired uropathogens at a tertiary care hospital in Jaipur, Rajasthan

Indian Journal of Community Medicine

Volumn 37, Issue 1, 2012, Pages 39-44

  Sood, Smita ^a   Gupta, Ravi ^b  

^a Super Religare Laboratories Ltd   (India)

^b FORTIS HOSPITAL   (India)

Author keywords

Escherichia coli; outpatients; Urinary tract infection

Indexed keywords

EID: 84859076116     PISSN: 09700218     EISSN: 19983581     Source Type: Journal    
DOI: 10.4103/0970-0218.94023     Document Type: Article

References (27)

1. Gales AC, Sader HS, Jones RN; The SENTRY Participants Group (Latin America). Urinary tract infection trends in Latin American hospitals: Report from the SENTRY antimicrobial surveillance program (1997-2000). Diagn Microbiol Infect Dis 2002;44:289-99.
2. Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm D. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother 2002;46:2540-5. (Pubitemid 34793461)
3. De Backer D, Christiaens T, Heytens S, de Sutter A, Stobberingh EE, Verschraegen G. Evolution of bacterial susceptibility pattern of Escherichia coli in uncomplicated urinary tract infections in a country with high antibiotic consumption: A comparison of two surveys with a 10 year interval. J Antimicrob Chemother 2008;62:364-8. (Pubitemid 351984782)
4. Rock W, Colodner R, Chazan B, Elias M, Raz R. Ten years surveillance of antimicrobial susceptibility of community acquired Escherichia coli and other uropathogens in Northern Israel. (1995-2005). Israel Med Assoc J 2007;9:803-5. (Pubitemid 350200980)
5. Vasquez Y, Hand WL. Antibiotic susceptibility patterns of community acquired urinary tract infection isolates from female patients on the US (Texas)-Mexico Border. J Appl Res 2004;4:321-6. (Pubitemid 39387312)
6. Griebling TL. Urinary tract infection in men. In: Litwin MS, Saigal CS, editors. Urologic Diseases in America. DHHS, PHS, NIH, NIDDK. Washington, DC: GPO;2007. NIH publication 07-5512:621-45.
7. Dimitrov TS, Udo EE, Emara M, Awni F, Passadilla R. Etiology and antibiotic susceptibility patterns of community acquired urinary tract infections in a Kuwait Hospital. Med Princ Pract 2004;13:334-9. (Pubitemid 39370432)
8. Habte TM, Dube S, Ismail N, Hoosen AA. Hospital and community isolates of uropathogens at a tertiary hospital in South Africa. South Afr Med J 2009;99:584-7.
9. Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community acquired urinary tract infections in JNMC Hospital, Aligarh, India. Ann Clin Microbiol Antimicrob 2007;6:6.
10. Kothari A, Sagar V. Antibiotic resistance in pathogens causing community acquired urinary tract infections in India: A multicentric study. J Infect Dev Ctries 2008;2:354-8.
11. Biswas D, Gupta P, Prasad R, Sinha V, Arya M, Kumar A. Choice of antibiotic for empirical therapy of acute cystitis in setting of high antimicrobial resistance. Indian J Med Sci 2006;60:53-8.
12. Colle JG, Miles RS, Watt B. Tests for identification of Bacteria. In Mackie and Mc Cartney's Practical Medical Microbiology. 14th ed. Edinburgh: Churchill Livingston;1996. p. 146.
13. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966;45:493-6.
14. Jarlier V, Nicolas M, Fournier G, Philippon A. Extended broad- spectrum α-lactamases conferring transferable resistance to newer α-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility pattern. Rev Infect Dis 1988;10:867-78.
15. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility test, 7th ed. Approved Standards, NCCLS Document M2-A7, Vol;20 no1; Wayne PA. 2000.
16. Kashef N, Djavid GE, Shahbaz S. Antimicrobial susceptibility patterns of community acquired uropathogens in Tehran, Iran. J Infect Dev Ctries 2010;4:202-6.
17. Das R, Chandrasekhar TS, Joshi HS, Gurung M, Shreshtha N, Shivananda PG. Frequency and susceptibility profile of pathogens causing urinary tract infections at a tertiary care hospital in western Nepal. Singapore Med J 2006;474:281-5.
18. Keah SH, Wee EC, Chng KS, Keah KC. Antimicrobial susceptibility of community acquired uropathogens in general practice. Malaysian Fam Physician 2007;2:64-9.
19. Kiffer CR, Mendes C, Oplustil CP, Sampio JL. Antibiotic resistance and trend of urinary pathogens in general outpatients from a major city. Int Braz J Urol 2007;33:42-9.
20. Hima-Lerible H, Menard D, Talarmin A. Antimicrobial resistance among uropathogen that cause community acquired urinary tract infections in Bangui, Central African Republic. J Antimicrob Chemother 2003;51:192-4. (Pubitemid 36163856)
21. Gupta V, Yadav A, Joshi RM. Antibiotic resistance pattern in uropathogens. Indian J Med Microbiol 2002;20:96-8.
22. Dias Neto JA, Martins AC, Tiraboschi RB, Domingos AL, Cologna AJ, Paschoalin EL, et al. Community acquired urinary tract infection: Etiology and bacterial susceptibility. Acta Cir Bras 2003;18(Suppl5):33-6.
23. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended spectrum α-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005;56:52-9. (Pubitemid 41418336)
24. Aggarwal R, Chaudhary U, Sikka R. Detection of extended spectrum α-lactamase production among uropathogens. J Lab Physicians 2009;1:7-10.
25. Tankhiwale SS, Jalgaonkar SV, Ahamad S, Hassani U. Evaluation of extended spectrum beta lactamase in urinary isolates. Indian J Med 2004;120:553-6. (Pubitemid 40202179)
26. Sire JM, Nabeth P, Perrier-Gros-Claude JD, Bahsoun I, Siby T, Macondo EA, et al. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal. J Infect Dev Ctries 2007;1:263-8.
27. Uzunovic-Kamberovic S. Antibiotic resistance of coliform organisms from community-acquired urinary tract infections in Zenica-Doboj Canton, Bosnia and Herzegovina. J Antimicrobial Chemother 2006;58:344-8. (Pubitemid 44294946)